OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+37.55%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$198M
AUM Growth
+$198M
(+54%)
Cap. Flow
+$32.3M
Cap. Flow
% of AUM
16.3%
Top 10 Holdings %
Top 10 Hldgs %
58.47%
Holding
43
New
13
Increased
10
Reduced
5
Closed
7
Top Buys
| 1 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$5.28M |
| 2 |
FibroGen
FGEN
|
$5.23M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$4.38M |
| 4 |
GNMX
Aevi Genomic Medicine, Inc.
GNMX
|
$4.3M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$3.51M |
Top Sells
| 1 |
InspireMD
NSPR
|
$4.59M |
| 2 |
BIND
BIND THERAPEUTICS INC
BIND
|
$3.87M |
| 3 |
Prothena Corp
PRTA
|
$3.48M |
| 4 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$2.93M |
| 5 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$1.92M |
Sector Composition
| 1 | Healthcare | 80.17% |
